162 related articles for article (PubMed ID: 16053715)
1. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues.
Park CH; Lee JH; Yang CH
J Biochem Mol Biol; 2005 Jul; 38(4):474-80. PubMed ID: 16053715
[TBL] [Abstract][Full Text] [Related]
2. New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex.
Hahm ER; Cheon G; Lee J; Kim B; Park C; Yang CH
Cancer Lett; 2002 Oct; 184(1):89-96. PubMed ID: 12104052
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos.
Handel ML; Watts CK; deFazio A; Day RO; Sutherland RL
Proc Natl Acad Sci U S A; 1995 May; 92(10):4497-501. PubMed ID: 7753832
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos.
Nikitovic D; Holmgren A; Spyrou G
Biochem Biophys Res Commun; 1998 Jan; 242(1):109-12. PubMed ID: 9439619
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells.
Park S; Lee DK; Yang CH
Cancer Lett; 1998 May; 127(1-2):23-8. PubMed ID: 9619854
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.
Prusty BK; Das BC
Int J Cancer; 2005 Mar; 113(6):951-60. PubMed ID: 15514944
[TBL] [Abstract][Full Text] [Related]
7. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.
Hahm ER; Gho YS; Park S; Park C; Kim KW; Yang CH
Biochem Biophys Res Commun; 2004 Aug; 321(2):337-44. PubMed ID: 15358181
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
9. AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells.
Berry A; Goodwin M; Moran CL; Chambers TC
Biochem Pharmacol; 2001 Sep; 62(5):581-91. PubMed ID: 11585055
[TBL] [Abstract][Full Text] [Related]
10. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
11. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
12. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
13. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
14. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
15. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of B-Raf increases c-Jun and c-Fos expression and upregulates AP-1-regulated gene transcription in insulinoma cells.
Langfermann DS; Rössler OG; Thiel G
Mol Cell Endocrinol; 2018 Sep; 472():126-139. PubMed ID: 29225069
[TBL] [Abstract][Full Text] [Related]
17. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
18. Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila.
Jindra M; Gaziova I; Uhlirova M; Okabe M; Hiromi Y; Hirose S
EMBO J; 2004 Sep; 23(17):3538-47. PubMed ID: 15306851
[TBL] [Abstract][Full Text] [Related]
19. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
20. Promoter specificity and biological activity of tethered AP-1 dimers.
Bakiri L; Matsuo K; Wisniewska M; Wagner EF; Yaniv M
Mol Cell Biol; 2002 Jul; 22(13):4952-64. PubMed ID: 12052899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
